First Tracks Biotherapeutics, Inc. (TRAX)
Nasdaq: TRAX · CIK 0002091349 · United States
Every official First Tracks Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TRAX filings
First Tracks Biotherapeutics, Inc. documents
- First Tracks Biotherapeutics, Inc. 10-K 2026TRAX 10-K 2026: annual report for fiscal 2026
- First Tracks Biotherapeutics, Inc. 10-K 2025TRAX 10-K 2025: annual report for fiscal 2025
- First Tracks Biotherapeutics, Inc. 10-K 2024TRAX 10-K 2024: annual report for fiscal 2024
- First Tracks Biotherapeutics, Inc. 10-K 2023TRAX 10-K 2023: annual report for fiscal 2023
- First Tracks Biotherapeutics, Inc. 10-K 2022TRAX 10-K 2022: annual report for fiscal 2022
- First Tracks Biotherapeutics, Inc. 10-Q 2026TRAX 10-Q 2026: quarterly report for fiscal 2026
- First Tracks Biotherapeutics, Inc. 10-Q 2025TRAX 10-Q 2025: quarterly report for fiscal 2025
- First Tracks Biotherapeutics, Inc. 10-Q 2024TRAX 10-Q 2024: quarterly report for fiscal 2024
- First Tracks Biotherapeutics, Inc. 10-Q 2023TRAX 10-Q 2023: quarterly report for fiscal 2023
- First Tracks Biotherapeutics, Inc. 10-Q 2022TRAX 10-Q 2022: quarterly report for fiscal 2022
- First Tracks Biotherapeutics, Inc. 8-K 2026TRAX 8-K 2026: current report for fiscal 2026
- First Tracks Biotherapeutics, Inc. 8-K 2025TRAX 8-K 2025: current report for fiscal 2025
- First Tracks Biotherapeutics, Inc. 8-K 2024TRAX 8-K 2024: current report for fiscal 2024
- First Tracks Biotherapeutics, Inc. 8-K 2023TRAX 8-K 2023: current report for fiscal 2023
- First Tracks Biotherapeutics, Inc. 8-K 2022TRAX 8-K 2022: current report for fiscal 2022
- First Tracks Biotherapeutics, Inc. DEF 14A 2026TRAX DEF 14A 2026: proxy statement for fiscal 2026
- First Tracks Biotherapeutics, Inc. DEF 14A 2025TRAX DEF 14A 2025: proxy statement for fiscal 2025
- First Tracks Biotherapeutics, Inc. DEF 14A 2024TRAX DEF 14A 2024: proxy statement for fiscal 2024
- First Tracks Biotherapeutics, Inc. DEF 14A 2023TRAX DEF 14A 2023: proxy statement for fiscal 2023
- First Tracks Biotherapeutics, Inc. DEF 14A 2022TRAX DEF 14A 2022: proxy statement for fiscal 2022
- First Tracks Biotherapeutics, Inc. Form 4 2026TRAX Form 4 2026: insider trading filing for fiscal 2026
- First Tracks Biotherapeutics, Inc. Form 4 2025TRAX Form 4 2025: insider trading filing for fiscal 2025
- First Tracks Biotherapeutics, Inc. Form 4 2024TRAX Form 4 2024: insider trading filing for fiscal 2024
- First Tracks Biotherapeutics, Inc. Form 4 2023TRAX Form 4 2023: insider trading filing for fiscal 2023
- First Tracks Biotherapeutics, Inc. Form 4 2022TRAX Form 4 2022: insider trading filing for fiscal 2022
- First Tracks Biotherapeutics, Inc. S-1 2026TRAX S-1 2026: registration statement for fiscal 2026
- First Tracks Biotherapeutics, Inc. S-1 2025TRAX S-1 2025: registration statement for fiscal 2025
- First Tracks Biotherapeutics, Inc. S-1 2024TRAX S-1 2024: registration statement for fiscal 2024
- First Tracks Biotherapeutics, Inc. S-1 2023TRAX S-1 2023: registration statement for fiscal 2023
- First Tracks Biotherapeutics, Inc. S-1 2022TRAX S-1 2022: registration statement for fiscal 2022
- First Tracks Biotherapeutics, Inc. 13F 2026TRAX 13F 2026: institutional holdings for fiscal 2026
- First Tracks Biotherapeutics, Inc. 13F 2025TRAX 13F 2025: institutional holdings for fiscal 2025
- First Tracks Biotherapeutics, Inc. 13F 2024TRAX 13F 2024: institutional holdings for fiscal 2024
- First Tracks Biotherapeutics, Inc. 13F 2023TRAX 13F 2023: institutional holdings for fiscal 2023
- First Tracks Biotherapeutics, Inc. 13F 2022TRAX 13F 2022: institutional holdings for fiscal 2022
More companies